[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@pick1998_2](/creator/twitter/pick1998_2) "$SRPT pivoting from AAV gene therapy/RNA splicing to siRNA therapies and broadened applications. A good direction. strong buy under 30"  [@pick1998_2](/creator/x/pick1998_2) on [X](/post/tweet/1945600798219800844) 2025-07-16 21:45:52 UTC 6902 followers, 6710 engagements "$CLRB insiders are buying after r-split and financing at discount. Will FDA BTD bring this biotech stock back to life"  [@pick1998_2](/creator/x/pick1998_2) on [X](/post/tweet/1940816738163347904) 2025-07-03 16:55:43 UTC 6902 followers, 1327 engagements "$GHRS has huge potential. Quicker Psychedelic Drugs Offer Investors a Better Trip Shorter-duration highscould help unlockcommercial viability for the sector"  [@pick1998_2](/creator/x/pick1998_2) on [X](/post/tweet/1943057552872518118) 2025-07-09 21:19:55 UTC 6902 followers, XXX engagements "$SRPT black box warning for Elevidys label resolving any materials issues. Back to 70"  [@pick1998_2](/creator/x/pick1998_2) on [X](/post/tweet/1945576114300358716) 2025-07-16 20:07:47 UTC 6902 followers, 2392 engagements "$MREO buy it now at XX% discount and forget it for a few months. Very likely it will recover when topline final data are announced by end of this year"  [@pick1998_2](/creator/x/pick1998_2) on [X](/post/tweet/1944774197437448259) 2025-07-14 15:01:15 UTC 6902 followers, 3587 engagements "$APLS PUDFA 7/28/25 sNDA of EMPAVELI(pegcetacoplan) for C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN) which are severe and rare kidney diseases. Priority Review. Approval should come. It should help reach profitability"  [@pick1998_2](/creator/x/pick1998_2) on [X](/post/tweet/1946231638557618231) 2025-07-18 15:32:36 UTC 6902 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@pick1998_2
"$SRPT pivoting from AAV gene therapy/RNA splicing to siRNA therapies and broadened applications. A good direction. strong buy under 30"
@pick1998_2 on X 2025-07-16 21:45:52 UTC 6902 followers, 6710 engagements
"$CLRB insiders are buying after r-split and financing at discount. Will FDA BTD bring this biotech stock back to life" @pick1998_2 on X 2025-07-03 16:55:43 UTC 6902 followers, 1327 engagements
"$GHRS has huge potential. Quicker Psychedelic Drugs Offer Investors a Better Trip Shorter-duration highscould help unlockcommercial viability for the sector" @pick1998_2 on X 2025-07-09 21:19:55 UTC 6902 followers, XXX engagements
"$SRPT black box warning for Elevidys label resolving any materials issues. Back to 70" @pick1998_2 on X 2025-07-16 20:07:47 UTC 6902 followers, 2392 engagements
"$MREO buy it now at XX% discount and forget it for a few months. Very likely it will recover when topline final data are announced by end of this year" @pick1998_2 on X 2025-07-14 15:01:15 UTC 6902 followers, 3587 engagements
"$APLS PUDFA 7/28/25 sNDA of EMPAVELI(pegcetacoplan) for C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN) which are severe and rare kidney diseases. Priority Review. Approval should come. It should help reach profitability" @pick1998_2 on X 2025-07-18 15:32:36 UTC 6902 followers, XXX engagements